Good morning and thank you for joining our call today. The attention of the insurance industry and of the world is on COVID-19. In discussing the impacts of this pandemic on Greenlight Re, I will first review its effect on our first quarter performance and then discuss considerations for the second quarter and beyond. On the liability side, the economic implications of lockdown and distancing vary by location, but became meaningful to many of our clients in the latter half of March. For Greenlight Re, the picture varies by underwriting class. In the auto class, our data suggests that claim counts started to drop in late March, although the apparent reduction may, in part, reflect the lag in claim reporting. In workers' compensation, we are tracking the small portion of our book that relates to ambulance and emergency medical personnel where we expect to see an increase in claims. Our exposure to other categories of essential workers is also relatively small. For the portion of our book exposed to industrial accidents, we see indications of reduced claim activity. The medical stock loss class is an area of possible exposure, but so far, there is no sign of increased claim activity, and policy deductibles generally position us above the cost of treatment for most COVID-19 cases. We are also expecting to see pandemic losses from our clients at Lloyd's, writing classes that include event cancellation and trade credit although our exposure in these areas is, again, relatively small. In sum, we have determined that overall COVID-19 had an immaterial impact on our first quarter, which produced a combined ratio of 98.9%. As the pandemic progresses, we anticipate further stresses and complications, including a reduction in premium revenue as some of our cedents may provide premium refunds to their policyholders. Similarly, we may see drops in exposure-rated premium and policy cancellations. The impacts on net income from premium reductions is less clear since these actions should generally be accompanied by a drop in claims. Possibly, the single biggest risk to the insurance industry is the potential for legislation to require insurers to pay business interruption claims despite the absence of the physical damage generally required by insurance contracts to trigger a claim payment. We expect that the U.S. plaintiffs' bar is determined to extract to win, and the outcome of this debate is unlikely to be determined any time soon. I should also note that as we are a reinsurance company with no direct insurance business, the caps in our contracts limit the tail exposure even in an extreme scenario such as the retroactive expansion of coverage. David will separately cover the investment performance where the market turmoil started significantly before the insurance event. In early April, the company announced the conclusion of its review of strategic transaction alternatives, concluding our belief that stockholder value will be better enhanced on a stand-alone basis than by pursuing a transaction with a third party. We have also expanded the share repurchase program, which reflects the confidence we have in the quality of our reserves and balance sheets and the opportunity presented by the market to increase shareholder value through buybacks. Tim will share the details of the repurchases in a few minutes. Now, I will pass the call over to David.
